This study is a randomized, double-blind, active-controlled, parallel, phase 3 study to evaluate efficacy and safety of NVP-1203 in patients with acute low back pain.
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with acute low back pain.